| BCBS Oklahoma Medical Policies | Facet Joint and Sacroiliac Joint Denervation | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Facet Joint Injections | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Faricimab-svoa | 2026-01-01 |
| BCBS Oklahoma Medical Policies | FDA - Drugs, Biologicals, Cellular and Gene Therapies | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Fetal Surgery for Prenatally Diagnosed Malformations | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Focal Treatments for Prostate Cancer | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Gastrointestinal Pathogen Panels | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Gender Assignment Surgery and Gender Reassignment | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Gene Therapies for Treatment of Wounds in Dystrophic | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Guselkumab | 2026-01-01 |